27.43
전일 마감가:
$28.17
열려 있는:
$28.17
하루 거래량:
16,091
Relative Volume:
0.05
시가총액:
$1.02B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.48%
1개월 성능:
+37.90%
6개월 성능:
+154.81%
1년 성능:
+0.37%
Oruka Therapeutics Inc Stock (ORKA) Company Profile
명칭
Oruka Therapeutics Inc
전화
650-606-7910
주소
855 OAK GROVE AVE., MENLO PARK
ORKA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ORKA
Oruka Therapeutics Inc
|
27.21 | 1.36B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.57 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.54 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.00 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-27 | 개시 | Guggenheim | Buy |
| 2025-10-13 | 개시 | Barclays | Overweight |
| 2025-05-22 | 개시 | BTIG Research | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-10-11 | 개시 | Stifel | Buy |
| 2024-10-07 | 개시 | H.C. Wainwright | Buy |
| 2024-09-17 | 개시 | Leerink Partners | Outperform |
| 2024-09-16 | 개시 | TD Cowen | Buy |
| 2024-09-13 | 개시 | Jefferies | Buy |
| 2018-02-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2013-10-09 | 개시 | Dawson James | Buy |
모두보기
Oruka Therapeutics Inc 주식(ORKA)의 최신 뉴스
Why retail investors favor Oruka Therapeutics Inc. stockForecast Cut & Capital Efficient Trade Techniques - newser.com
Can Oruka Therapeutics Inc. stock sustain market leadershipQuarterly Investment Review & Precise Buy Zone Identification - newser.com
How Oruka Therapeutics Inc. (HQ1) stock behaves in tightening cycles2025 Performance Recap & Stepwise Trade Execution Plans - newser.com
What valuation ratios show for Oruka Therapeutics Inc. (HQ1) stockJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
Is Oruka Therapeutics Inc. (HQ1) stock undervalued at current priceMarket Rally & High Conviction Buy Zone Alerts - newser.com
Why Oruka Therapeutics Inc. stock attracts global investorsEarnings Overview Summary & Low Drawdown Momentum Trade Ideas - newser.com
Will Oruka Therapeutics Inc. stock recover faster than marketCPI Data & Weekly Return Optimization Plans - newser.com
Will Oruka Therapeutics Inc. (HQ1) stock return to pre crash levels2025 Support & Resistance & Safe Entry Zone Tips - newser.com
Is Oruka Therapeutics Inc. stock supported by strong cash flowsTrade Analysis Report & Short-Term Trading Opportunity Alerts - newser.com
What technical patterns form on Oruka Therapeutics Inc. (HQ1) stock chartsPortfolio Risk Summary & AI Powered Market Trend Analysis - newser.com
Will Oruka Therapeutics Inc. stock outperform growth indexes2025 Sector Review & AI Based Buy/Sell Signal Reports - newser.com
Can Oruka Therapeutics Inc. (HQ1) stock hold up in economic slowdownJuly 2025 Decliners & Advanced Technical Analysis Signals - newser.com
What analysts say about Oruka Therapeutics Inc stockCovered Call Writing & Control Your Emotions With Discipline Tools - earlytimes.in
Published on: 2025-10-31 04:52:14 - newser.com
Price action breakdown for Oruka Therapeutics Inc.Insider Buying & Verified Entry Point Detection - newser.com
Volume spikes in Oruka Therapeutics Inc. stock – what they meanChart Signals & Consistent Profit Alerts - newser.com
Pattern recognition hints at Oruka Therapeutics Inc. upside2025 Historical Comparison & Reliable Volume Spike Alerts - newser.com
Will Oruka Therapeutics Inc. stock go up soonGap Down & Entry and Exit Point Strategies - newser.com
HC Wainwright Brokers Raise Earnings Estimates for ORKA - MarketBeat
Key metrics from Oruka Therapeutics Inc.’s quarterly dataWeekly Gains Summary & Risk Managed Trade Strategies - newser.com
Is Oruka Therapeutics Inc. stock a bargain at current levels2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Q3 EPS Forecast for Oruka Therapeutics Boosted by Analyst - Defense World
Published on: 2025-10-29 21:32:46 - newser.com
Wall Street Analysts Predict a 63.59% Upside in Oruka Therapeutics, Inc. (ORKA): Here's What You Should Know - sharewise.com
Oruka Therapeutics to Present at Multiple November Investor Conferences - The Manila Times
Oruka Therapeutics (NASDAQ:ORKA) Now Covered by Analysts at Guggenheim - Defense World
Oruka Therapeutics Inc (ORKA) 재무 분석
Oruka Therapeutics Inc (ORKA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Oruka Therapeutics Inc 주식 (ORKA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Par | 10% Owner |
Feb 13 '25 |
Buy |
11.63 |
14,950 |
173,868 |
4,059,634 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 12 '25 |
Buy |
11.86 |
8,971 |
106,396 |
4,044,684 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 11 '25 |
Buy |
10.95 |
9,593 |
105,043 |
4,035,713 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 10 '25 |
Buy |
10.90 |
574 |
6,257 |
4,026,120 |
자본화:
|
볼륨(24시간):